tiprankstipranks
Target Healthcare REIT (GB:THRL)
:THRL
UK Market
Holding GB:THRL?
Track your performance easily

Target Healthcare REIT (THRL) Income Statement

26 Followers

Target Healthcare REIT Income Statement

Last quarter (Q2 2023), Target Healthcare REIT's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Target Healthcare REIT's net income was $―. See Target Healthcare REIT’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ ―$ 85.03M$ 112.59M$ 52.27M$ 50.70M$ 37.84M
Cost of Revenue
$ ―$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―$ ―$ ―$ ―
Operating Expense
$ ―$ ―$ ―$ ―$ ―$ ―
Operating Income
$ ―$ ―$ ―$ ―$ ―$ ―
Net Non Operating Interest Income Expense
$ ―$ ―$ ―$ ―$ ―$ ―
Other Income Expense
$ ―$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ 73.02M$ 101.47M$ 38.00M$ 43.88M$ 31.62M
Tax Provision
$ ―$ ―$ ―$ 6.00K$ -8.00K$ -3.00K
Earnings From Equity Interest Net Of Tax
$ ―$ ―$ ―$ ―$ ―$ ―
Net Income Common Stockholders
$ ―$ 73.02M$ 101.47M$ 37.99M$ 43.88M$ 31.62M
Basic EPS
$ ―$ 0.12$ -0.01$ 0.08$ 0.09$ 0.07
Diluted EPS
$ ―$ 0.12$ -0.01$ 0.08$ 0.09$ 0.07
Basic Average Shares
$ ―$ 620.24M$ 620.24M$ 598.74M$ 475.41M$ 440.28M
Diluted Average Shares
$ ―$ 620.24M$ 620.24M$ 598.74M$ 511.54M$ 440.28M
Dividend Per Share
$ ―$ 5.68$ 6.47$ 0.07$ 0.07$ 0.07
Total Operating Income As Reported
$ ―$ ―$ ―$ ―$ ―$ ―
Reported Normalized Basic E P S
$ ―$ ―$ ―$ ―$ ―$ ―
Reported Normalized Diluted E P S
$ ―$ ―$ ―$ ―$ ―$ ―
Rent Expense Supplemental
$ ―$ ―$ ―$ ―$ ―$ ―
Total Expenses
$ ―$ ―$ ―$ ―$ ―$ ―
Net Income From Continuing And Discontinued Operation
$ ―$ 73.02M$ 101.47M$ 37.99M$ 43.88M$ 31.62M
Normalized Income
$ ―$ 54.77M$ 82.19M$ 30.78M$ 43.87M$ 31.62M
Interest Expense
$ ―$ 11.22M$ 9.89M$ 6.10M$ 4.28M$ 3.62M
EBIT
$ ―$ ―$ ―$ ―$ ―$ ―
EBITDA
$ ―$ ―$ ―$ ―$ ―$ ―
Currency in USD

Target Healthcare REIT Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis